Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,754.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 6,070.00p
  • 52 Week Low: 2,234.00p
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 65,535
  • Market Cap: £1,811.41m
  • RiskGrade: 128

Genus Overview

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.
Registrars: Equiniti

Key Personnel

Non-Executive Chairman: Iain Ferguson
CEO: Stephen Wilson
CFO: Alison Henriksen
Independent Non-Executive Director: Lykele van der Broek
Independent Non-Executive Director: Lysanne Gray
Independent Non-Executive Director: Jason Chin
Senior Independent Director: Lesley Knox
Non-Executive Dir:

Contact Details

Address: Matrix House, Basing View, Basingstoke, Hampshire, United Kingdom, RG21 4DZ
Phone: +44 (0) 1256 347 100
Fax: +44 (0) 1256 477 385
Website: http://www.genusplc.com

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:GNSL
ISIN: GB0002074580

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,754.00p
Change Today -10.00p
% Change -0.36 %
52 Week High 6,070.00p
52 Week Low 2,234.00p
Volume 65,535
Shares Issued 65.77m
Market Cap £1,811.41m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.86% below the market average94.86% below the market average94.86% below the market average94.86% below the market average94.86% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Price Trend Not Available
Income
87.54% below the market average87.54% below the market average87.54% below the market average87.54% below the market average87.54% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
41.91% above the market average41.91% above the market average41.91% above the market average41.91% above the market average41.91% above the market average
64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 12-Aug-2022

Time Volume / Share Price
16:35 3,898 @ 2,754.00p
16:35 26,912 @ 2,754.00p
16:29 5 @ 2,744.00p
16:27 1,286 @ 2,738.00p
16:25 73 @ 2,744.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page